Sparc (Osteonectin), a matricellular glycoprotein expressed by many differentiated cells, is a major non-collagenous constituent of vertebrate bones. Recent studies indicate that Sparc expression appears early in development, although its function and regulation during embryogenesis are largely unknown. We cloned zebrafish sparc and investigated its role during development, using a mo rpholino antisense oligonucleotide-based knockdown approach. Consistent with its strong expression in the otic vesicle and developing pharyngeal cartilages, knockdown of Sparc function resulted in specific inner ear and cartilage defects that are highlighted by changes in gene expression, morphology and behavior. We rescued the knockdown phenotypes by co-injecting sparc mRNA, providing evidence that the knockdown phenotype is due specifically to impairment of Sparc function. A comparison of the phenotypes of Sparc knockdown and known zebrafish mutants with similar defects places Sparc downstream of sox9 in the genetic network that regulates development of the pharyngeal skeleton and inner ear of vertebrates.
Introduction
Sparc (secreted protein, acidic and rich in cysteine), also known as Osteonectin or BM-40 (basement membrane tumor matrix component), is a secreted calcium-binding glycoprotein that belongs to the matricellular protein family (Yan and Sage, 1999) . Rather than acting as structural components of the extracellular matrix, members of this family mediate cell-matrix interactions (Bornstein, 1995) . Sparc is a multifunctional protein with a high affinity for cations and hydroxyapatite that provides support to extracellular matrix and mediates the activities of a wide range of growth factors (Brekken and Sage, 2001 ).
Phenotypic abnormalities revealed by loss-of-function studies also support the interpretation that Sparc mainly functions in cell-matrix interactions (Gilmour et al., 1998; Delany et al., 2003; Bradshaw et al., 2002; Bradshaw et al., 2003; Brekken et al., 2003; Eckfeldt et al., 2005) .
Initially purified from bovine bone matrix (Termine et al., 1981) , Sparc is also found in embryonic and adult tissues that undergo active proliferation and dynamic morphogenesis (Holland et al., 1987; Sage et al., 1989; Damjanovski et al., 1994; Yan and Sage, 1999; Damjanovski et al., 1998; Bradshaw and Sage, 2001; Padhi et al., 2004; Renn et al., 2006a,b) . With few exceptions, most animal species have a single Sparc-encoding gene (Laize et al., 2005) . Sequence analysis reveals more than 70% amino acid identity among vertebrate Sparcs, whereas vertebrate and invertebrate Sparcs share only 38% identity (Yan and Sage, 1999; Laize et al., 2005) . Surprisingly, no mutations in this gene have been identified in humans, although mouse Sparc mutants display various phenotypic abnormalities, such as cataracts, Available online at www.sciencedirect.com Matrix Biology 27 (2008) 561 -572 www.elsevier.com/locate/matbio osteopenia, accelerated closure of dermal wounds, increased adiposity and enhanced growth of tumors (Gilmour et al., 1998 , Delany et al., 2003 , Bradshaw et al., 2002 , Brekken et al., 2003 . Knockout mice deficient for Sparc are normal when born, but develop severe eye pathology including cataracts, as well as tail defects and other bone-related defects after birth. The late onset of defects is likely due to severely reduced numbers of differentiated osteoblasts (Delany et al., 2003) . However, studies carried out in other organisms suggest an important role for Sparc in early development. Inappropriate expression of Sparc in Xenopus embryos has dramatic affects on tissue morphogenesis (Damjanovski et al., 1998) , whereas inactivation of Sparc in C. elegans by RNA interference suggests that Sparc is required for embryo viability (Fitzgerald and Schwarzbauer, 1998) . It has been hypothesized that the presence of other members of the SPARC family functionally compensate for the lack of SPARC expression (Brekken and Sage, 2001 ), leading to mild defects in SPARC-null mice. Therefore, in other organisms, such as C. elegans, where there is less redundancy, reduction in SPARC produces much more significant defects including embryonic lethality (Fitzgerald and Schwarzbauer, 1998) .
Phylogenetic analyses of genome data indicate that gene duplication of SPARC gave rise to SPARCL1 (SPARC like-1), which in turn served as the common ancestral gene for the secretory calcium-binding phosphoprotein family (SCPPs), after the divergence of cartilaginous fish and bony fish but before the divergence of zfish and mammalian lineages. This implies that early vertebrate mineralization did not use SCPPs and that SPARC may be critical for initial mineralization in all bony fish (osteoichthyes). Consistent with this inference, no genes orthologous to mammalian enamel proteins, constituents of the secretory calcium-binding phosphoprotein (SCPP) family, have been identified in teleosts. Therefore, mammals apparently have more SPARC or SPARCL1 functional homologs than teleosts. Consequently, our observations in zebrafish likely uncover the significant roles of sparc.
Thus, the precise function of Sparc, especially during early embryogenesis, remains largely unknown. A recent report indicates that expression of the medaka sparc gene can serve as an early marker for skeletal and extracellular matrix (Renn et al., 2006a,b) . Its dynamic expression pattern during embryogenesis, similar to other vertebrates, suggests a conserved function of Sparc in vertebrates (Renn et al., 2006a,b) .
Here, we provide the first functional study of Sparc in zebrafish. We found that the zebrafish sparc gene is expressed in a temporally and spatially specific manner, with strong expression in the developing inner ear and pharyngeal cartilage. Knockdown of Sparc function by morpholino antisense oligonucleotides (MOs) produced a developmental phenotype that corresponds well to its expression pattern. We have further shown that Sparc interacts with genes in known genetic networks, unveiling its novel functions in regulating pharyngeal cartilage and inner ear development.
Results

Conserved syntenies confirm that sparc is the zebrafish ortholog of human SPARC
Although sequences called sparc have been deposited in Genbank (Renn et al., 2006a,b; Lien et al., 2006; Whitehead et al., 2005; Padhi et al., 2004; Kawasaki et al., 2004) , there has as yet been no analysis of conserved syntenies of the zebrafish sparc gene. SPARC is on the long arm of human chromosome 5 (Hsa5) (Fig. 1A) , and immediately adjacent are ATOX1, G3BP1, and GLRA1 (Fig. 1B) . The best reciprocal blast hits (RBH) for two of these human genes lie as immediate neighbors of zebrafish sparc (Fig. 1C) on linkage group 14 (LG14) (Fig. 1D) . Because RBH is a generally recognized method for . In both species, sparc or SPARC and two of the three closest neighbors on one side are arranged in the same order, thus demonstrating conservation of this chromosome segment in both lineages from the last common ancestor of zebrafish and humans. The human ATOX1 gene does not appear to have an ortholog in the zebrafish genome (Zv7) (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) the identification of likely orthologs (Wall et al., 2003) , we conclude that these zebrafish genes are orthologs of G3BP1 and GLRA1 in the human genome. This evidence shows that, except for the loss of an ortholog of ATOX1, this region of the genome has been retained intact in gene order (sparc-g3bp1-glra1) for 450 million years since the divergence of the human and zebrafish lineages. The orthology of two genes adjacent to sparc and SPARC provides strong support for the orthology of sparc and SPARC, independent of phylogenetic trees (Laize et al., 2005) .
Sparc is expressed dynamically in early zebrafish embryos
By RT-PCR, we detected sparc transcripts initially by 14 h post-fertilization (hpf), and expression subsequently increased and persisted ( Fig. 2A) . Whole-mount mRNA in situ hybridization showed that the otic placode was the initial site of strong expression in 14 hpf embryos (data not shown). By 24 hpf, sparc transcripts were present in the caudal fin fold, notochord, floor plate and somites, in addition to the otic vesicle ( Fig. 2B-D) . At 72 hpf, sparc messenger RNA was still detectable in the otic vesicle, epidermal fin folds and floor plate but not in the notochord (Fig. 2E and data not shown), with additional expression in the pharyngeal skeleton, operculum, scapulocoracoid, endochondral disc, pectoral fin and pronephros ( Fig. 2E -G and data not shown). Thus, zebrafish and medaka share a very similar expression pattern of sparc during embryogenesis (Renn et al., 2006a,b) . Similar results were also found in mouse, were sparc transcripts were detected in developing tissues, such as the otic vesicle (Mothe and Brown, 2001) , notochord, somites and the embryonic skeleton (Holland et al., 1987; Mason et al., 1986) .
Morpholino blockade of Sparc expression and splicing
To analyze the roles sparc plays in development, we took a loss-of-function approach: we designed antisense oligonucleotide morpholinos (MOs) to inhibit sparc translation and splicing (ATG-MO and E3I3-MO in Fig. 3A -B, respectively) in developing embryos. The specificity and efficacy of the morpholinos were analyzed either by their ability to inhibit protein translation in an in vitro transcription-translation assay (Fig. 3A) or their efficacy at inhibiting transcript processing in vivo as assayed by RT-PCR (Fig. 3C) . The ATG-MO specifically blocked Sparc protein synthesis but had no effect on Smyd1a translation in the TNT assay. To demonstrate the efficacy of inhibition in vivo, we designed a splice-blocking morpholino targeted against the third coding exon-intron donor boundary (Fig. 3B ). When injected into zebrafish embryos, the splice-blocking morpholino resulted in the accumulation of a new transcript (401 bp) due to the retention of the first 95 bp of intron 3 sequence as confirmed by sequencing the RT-PCR products of the sparc transcript from the knockdown embryos (Fig. 3C ). This produced a transcript that is predicted to include a premature termination codon (33 amino acids after the splice site), thus encoding a peptide that lacks the highly conserved and likely essential C-terminal collagen and calcium-binding domains (Laize et al., 2005) . Quantitative analysis showed that 68% of the sparc transcripts were incorrectly spliced in embryos injected with 1 nl of 0.5 mM E3I3-MO, and injection of 1 nl of 1 mM E3I3-MO resulted in 100% improperly spliced transcripts ( Fig. 3C ), compared with control MO-injected or non-injected 48 h embryos.
Thus, the specific inhibition of Sparc activity was MO dose dependent. By titrating the amount of MO injected, we determined the optimal MO doses that generated reproducible phenotypes without causing early lethality: 1 nl of ATG-MO at a concentration of 0.5 mM, and 1 nl of E3I3-MO at a concentration of 1 mM. We injected these doses into 1-to 2-cell stage embryos, and examined development for 7 days. These embryos survived to 4 days postfertilization (dpf), and about 20% were alive at 5 dpf, although none survived beyond 7 dpf. Most injected embryos developed normally until 30 hpf, when they appeared significantly smaller than the control MO-injected or uninjected embryos. MO-injected embryos were approximately 15% shorter in length and developed smaller and kinked pectoral fins ( Fig. 4C-D) . Among MOinjected animals, 81% (n = 350) showed a severe reduction of their lower jaws ( Fig. 4A-B) , although dorsal components were relatively unaffected. Most MO-injected animals (79%) displayed vestibular dysfunction, i.e., swimming or resting on their sides and circling only upon stimulation, consistent with a functional defect in the ear. The cartilage and inner ear phenotypes occur concurrently in almost all morpholino-injected animals (94%). Both morpholino strategies produced a similar phenotype in vivo, which was not observed in embryos injected with a scrambled control morpholino.
Sparc is required for pharyngeal cartilage morphogenesis
To analyze the lower jaw defects, we monitored cartilage patterning by Alcian blue staining ( Fig. 4E-H) . The cartilagenous neurocranium appeared relatively smaller but normally patterned after MO injection ( Fig. 4F-H) . In contrast, knockdown of Sparc resulted in absent or severely reduced Meckel's and ceratohyal cartilages ( Fig. 4F-H) , and the pharyngeal arches (ceratobranchials 1-5) failed to form (Fig. 4G-H) . To learn whether Sparc knockdown affects the neural crest that is involved in cartilage patterning, we examined the expression of dlx2a in the subset of premigratory and post-migratory cranial neural crest cells that give rise to the pharyngeal arches (Akimenko et al., 1994; Miller at al., 2000) . Expression of dlx2a was essentially normal after Sparc knockdown ( Fig. 3O-P) . In contrast, col2a1a expression, which marks differentiating chondrocytes (Yan et al., 1995) , was In lane 4, the 401 bp band, which is the major PCR product, is a result of defective splicing due to use of a cryptic splice donor located 95 bp 3′ of the normal exon 3/intron 3 splice site in intron 3 as shown by DNA sequencing (data not shown).
significantly reduced (Fig. 4I-J) . This phenotype is similar to the phenotypes of sox9 mutants we previously observed (Yan et al., 2005) where col2a1a expression is substantially reduced.
To understand the possible relationship of col2a1a, sox9 and sparc expression, we analyzed expression of sox9 genes in sparc knockdown embryos, and found that sox9a and sox9b expression domains were essentially normal ( Fig. 4K-N) . Moreover, we found that sparc expression was substantially reduced or missing from the pharyngeal arches of sox9a (jef hi1134 ), sox9b (Df b971 ) and jef hi1134 (Df b971 ) mutants (Fig. 5) , suggesting that Sparc functions downstream of sox9a and upstream of col2a1a in the cascade of genes that regulate cartilage morphogenesis. However, it should be also noted that although sox9a and sox9b expression domains were patterned normally at 24 hpf after Sparc knockdown, their expression levels appeared somewhat reduced (Fig. 4K-N) , suggesting that Sparc may provide positive feedback regulation of Sox9 expression.
Sparc is required for inner ear morphogenesis
Consistent with its strong and early expression in the otic placode, Sparc knockdown produced defects in the otic vesicle. To characterize these defects, we used known markers to monitor otic development (dlx3b, eya1, and cldna), specification (stm and cldna), and morphogenesis (otx1, atp1a1a.4, msxc). All markers except otx1 showed normal expression in MO-injected embryos at 24 hpf, suggesting that Sparc function is not required for otic induction or development through 24 hpf ( Fig. 6A-H) . However, otx1 expression, which normally indicates the ventral epithelial region and developing posterior macula (Hammond et al., 2003) , was absent or largely reduced in Sparc knockdown embryos (Fig. 6I-J) . By 68 hpf, the ear was markedly smaller after Sparc knockdown, and the epithelial projections of the semicircular canals, although present, failed to connect with each other to form the canals (Fig. 7A-B) , and formation of the lateral and posterior semicircular canals was significantly disrupted. The otoliths however were present, consistent with the normal appearance of starmaker expression (Fig. 7A-B) . Absence of atp1a1a.4 expression further indicated the possible disruption of lateral and posterior semicircular canal formation (Fig. 7D) . Examination of msxc expression, which normally marks the developing cristae, indicated failure of lateral crista development in MO-treated (E, lateral view, and G, ventral view) and sparc MO-injected (F, lateral view, and H, ventral view) embryos. Note the lack of differentiated pharyngeal arches in the MO-injected embryos (F and H). The cartilage in the ethmoid plate (ep) and the trabecula (tr) is relatively unaffected in the MOinjected embryo (I-J) Whole-mount mRNA in situ hybridization analysis of col2a1 expression in 72 hpf embryos. In sparc MO-injected embryos (ventral views), col2a1 expression is strongly reduced, although not completely absent (J). (K-N) Whole-mount mRNA in situ hybridization analysis of sox9a and sox9b expression in 24 hpf embryos. (O-P) Whole-mount mRNA in situ hybridization analysis of dlx2a expression in 24 hpf embryos. By this stage, embryos have formed four pairs of pharyngeal arches, the mandibular (1), hyoid (2), and the first (3) and second (4) pharyngeal arches. Abbreviations: m, Meckel's cartilage; e, eye; ep, ethmoid plate; ch, ceratohyal; ov, otic vesicle; pa, pharyngeal arches; pq, palatoquadrate; r, rhombomeres; tr, trabecula. (A-P) anterior to the left; (A-B, E-F, K-P) dorsal to the top; Scale bars: (A-B) 100 μm; (C-J) 100 μm; (K-P) 100 μm. animals ( Fig. 7E-F) . The order of appearance of these elements excludes nonspecific developmental delay as the cause of the phenotype. FITC-phalloidin, which highlights actin-rich stereocilia of the ear sensory hair bundles, showed that in sparc MOinjected animals, the anterior and posterior maculae were closer to each other than in controls, presumably due to the loss of otx1 expression between the two maculae ( Fig. 7G-H ).
sparc mRNA rescues defects caused by sparc MOs
To verify further the specificity of the defects produced by Sparc knockdown, we rescued ATG-MO and E3I3-MO-injected embryos by co-injecting synthetic sparc mRNA with a modified ATG-MO binding site. Nearly complete rescue was achieved. The drastic reduction of differentiated cartilage after Sparc knockdown was rescued by co-injection of wild-type mRNA ( Fig. 8A-H) . The penetrance and severity of the phenotype was dose dependent. We had better success rescuing the spliceblocking morpholino phenotypes; approximately 60% rescue in 1 mM E3I3-MO plus 750 μg/ml mRNA compared to 36% with 0.5 mM ATG-MO plus 750 μg/ml mRNA (50 embryos). Similarly, the defects in ear differentiation, as indicated by various gene markers, were almost completely rescued by wildtype mRNA injection (Fig. 8L-T) . col2a1 expression in the notochord was also rescued (Fig. 8I-K) , although the body shape was still somewhat abnormal. These results demonstrate that exogenous wild-type sparc is sufficient to correct the defects in the otic vesicle and pharyngeal cartilage caused to sparc MOs, consistent with the interpretation that these developmental defects are due to reduced levels of Sparc protein function.
Discussion
We examined the function of Sparc during development of zebrafish embryos and larvae. Previous studies of other teleosts (seabream and medaka) showed that sparc is dynamically expressed in skeletal and non-skeletal tissues from early development to adulthood, suggesting a potentially wide range of action Renn et al., 2006a,b) . The predicted zebrafish Sparc protein shares high similarity to the Sparc proteins of other vertebrates (Renn et al., 2006a ,b, Laize et al., 2005 and analysis of conserved syntenies provides independent evidence of orthology. Furthermore, the expression pattern of zebrafish sparc is comparable to medaka and sea bream (Renn et al., 2006a,b; Redruello et al., 2005 . Based on previous studies that suggested Sparc may have numerous functions at late developmental stages, for instance, after birth in Sparc knock out mice (Yan and Sage, 1999) , we anticipated a broad range of defects. Instead, we find that sparc functions mainly in the developing pharyngeal cartilage and inner ear, structures in which it is strongly expressed during early development.
We find that Sparc plays an important role in regulating pharyngeal cartilage development, but dlx2 expression in sparc knockdown animals showed that sparc is not required for morphogenesis of the migratory and post-migratory cranial neural crest that contributes to the pharyngeal cartilage. We previously showed that sox9 genes play a key role in chondrocyte morphogenesis (Yan et al., 2002 (Yan et al., , 2005 . The defects in differentiated (Alcian blue positive) cranial cartilage observed in sox9 mutants (Yan et al., 2005) are similar to those in sparc MO-injected animals, suggesting that Sparc is directly involved in differentiation of cells within pharyngeal precartilage condensations and that Sparc mediates at least some of the phenotypic defects of sox9 mutants. The drastic reduction of col2a1a expression after sparc MO injection supports this interpretation. Because we also observed some reduction in the expression of both sox9 genes in sparc MO-injected animals, reduced col2a1 expression after sparc MO injection could also indicate an indirect effect due to down regulation of sox9 gene expression. Sox9 function is required for three morphogenetic processes in cartilage development: formation of orderly stacks of chondrocytes (Akiyama et al., 2002 , Yan et al., 2002 , the individualization of cartilages (Kronenberg, 2003 , Kawakami et al., 2006 , and the shaping of specific skeletal elements (Yan et al., 2002) . Whether these processes require a counteradhesive effect on focal adhesions (Motamed and Sage, 1997) , cell-matrix interactions that lead to additional cell recruitment, and/or Sparc-mediated signal transduction is still unclear.
The high mortality rate (100% by 7 dpf) of MO-injected animals is presumably due to the defects in the pharyngeal arches; the animals cannot feed and blood circulation through the aortic arches is impaired. Thus, the effect of Sparc knockdown on later development, such as the mineralization process, could not be determined.
In this study, we also demonstrated that Sparc knockdown produces a prominent and highly specific defect in inner ear development, failure to form the horizontal semicircular canal and lateral crista, and abnormal fusion of anterior and posterior maculae. The inner ear develops from the otic placode, a specialized ectodermal thickening that later forms the membranous labyrinth of the inner ear through a process of epithelial growth and remodeling (Haddon and Lewis, 1991; Barald and Kelley, 2004) . We can rule out a role of Sparc in early ear induction and patterning, because the ear vesicle forms normally and the majority of known ear markers (Liu et al., 2003) exhibit essentially normal expression after Sparc knockdown. The later ear defects due to Sparc knockdown thus indicate a role in differentiation of sub-parts of the ear. These defects are very similar to the ear defects of Otx1 knockdown animals (Hammond and Whitfield, 2006) , and Sparc knockdown disrupt otx1 expression in the ear. Hammond and Whitfield (2006) recently pointed out that because otx1 is expressed in the zebrafish ear but not lamprey ear, otx1 expression may reflect an evolutionary gain of the third semicircular canal and crista, and a subdivision of the single macula during evolution from agnathan to gnathostome vertebrates. The ear defects due to Sparc knockdown thus reveal an important yet unique developmental role of Sparc in the more recently evolved auditory sensory organ.
Because Otx1 is also expressed in pharyngeal arches and skeletal elements (Thisse et al., 2004) , it is possible that pharyngeal defects in sparc MO-injected animals are partially due to a loss of otx1 expression and partially due to feedback regulation of sox9 genes by Sparc. These inferences raise a puzzling question of how a matricellular protein can regulate expression of transcription factor genes, in this case otx1 and sox9. The role of Sparc in cell-matrix interactions may hold the answer; Sparc may mediate or trigger signal transduction pathways required for activation or maintenance of target gene transcription. This notion could be explored by identifying extracellular signaling molecules that act upstream of the genes encoding Sox9, Otx1 and Sparc. We recently learned that Fgfs are regulators of sox9 gene expression in the ear (Hans et al., 2007 and unpublished observations) , and an earlier report indicates that mutations in fgf20a down regulate sparc expression and block the initiation of fin regeneration (Whitehead et al., 2005) . Thus, members of the Fgf family of signaling molecules may be good candidates for signaling molecules that interact with Sparc.
Experimental procedures
Experimental animals
Zebrafish embryos were cultured as previously described (Westerfield, 2007) and staged by standard criteria (Kimmel et al., 1995) or by h (hpf) or days (dpf) post-fertilization. Experiments were performed using the AB wild-type strain (Zebrafish International Resource Center) and sox9a (jef hi1134 ) and sox9b (Df(LG03:sox8,sox9b) b971 ) mutants (Yan et al., 2005) . To inhibit embryo pigmentation, embryo medium was supplemented with 0.003% (w/v) 2-phenylthiourea (Westerfield, 2007) . For histology, dechorionated embryos were fixed overnight at 4°C in 4% paraformaldehyde in 1× PBS, washed in PBS, and either stored at 4°C in 1× PBS for FITC-phalloidin and cartilage staining, or dehydrated through a methanol series and stored at −20°C in 100% methanol for in situ hybridization.
RNA isolation and RT-PCR
The full length transcript of zebrafish sparc was obtained by RT-PCR (GenBank Accession Number: BC071436). Total RNA was extracted from zebrafish embryos at 0, 3, 6, 9, 12, 14 and 19 hpf and 1, 2, 3, 4, 5 and 6 dpf using TRIzol (Invitrogen) . Firststrand cDNA was synthesized according to the Life Science Inc. protocol using AMV reverse transcriptase. The PCR reaction mixtures were prepared using the PCR Master Mix (Promega) and PCR was performed for 35 cycles under standard conditions at 58°C annealing temperature. Temporal expression profiles of sparc were determined by RT-PCR using the primers (5′ primer/ 3′ primer), TGCTTAGGCTGAAACTCAAGATGAG/GCAT-CAATGGAAGACGTCCTTAGAT. PCR was also carried out to amplify ef1a cDNA as a positive control.
Morpholino knockdown
Morpholino antisense oligonucleotides (MOs) were synthesized by GeneTools (Corvallis, OR). Two independent MOs, a translation blocker (ATG-MO: 5′GATCCAAACCCTCATCTT-GAGTTTC3′) and a splicing blocker (E3I3-MO: 5′GAAAAAT-GAACTCACTCTCAGCAAT3′), were used to target sparc. A scrambled MO with no known target in zebrafish, cMO, 5′-CCTCTTACCTCAGTTACAATTTATA-3′ was used as control. The MOs were resuspended in 1× Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO 4, 0.6 mM Ca(NO 3 ) 2 , 5 mM HEPES, pH 7.6) to a final concentration of 0.5 mM or 1 mM. Approximately, 1 nl was injected into one-or two-cell stage embryos. Eckfeldt et al. (2005) used an ATG-MO against sparc in a hematopoietic defect study but did not report any cartilage and inner ear defects. The first 12 bases of their MO are identical to the last 12 bases of our independently designed ATG-MO.
Morpholino specificity
The efficacy of the MOs to block translation or splicing of sparc specifically was analyzed using either an in vitro translation assay or RT-PCR.
Function of the ATG-MO was assessed in an in vitro transcription and translation-coupled system (TNT Coupled Reticulocyte Lysate Systems; Promega). The amplified full length sparc cDNA was subcloned into the pCS2+ vector. The pCS2+ vector utilizes the SP6 RNA polymerase binding site that can be used directly for in vitro transcription-translation assays. The assay was performed according to the instructions provided with the Promega TNT Coupled Reticulocyte Lysate Systems using [alpha][
35 S] methionine. The synthesized proteins were analyzed by SDS gel electrophoresis on a 10% acrylamide gel and visualized by autoradiography after 2 h exposure at room temperature. pCS2 + -smyd1a (Tan et al., 2006 ) was used as a control for this assay.
To test for disruption of splicing, RT-PCR was performed (primers: exon 1 forward, 5′GCTGAAACTCAAGATGAG-3′; exon 4 reverse, 5′-TCCAATCGGAGACTTCGAGCA-3′). Total RNA from 15 uninjected 48 hpf embryos, 15 embryos injected with 1 nl of 1 mM cMO, 15 embryos injected with 1 nL of 0.5 mM E3I3-MO and 15 embryos injected with 1 nL of and 1 mM E3I3-MO were collected, the cDNA transcribed following the above protocol.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed using digoxigenin-labeled antisense probes as previously described (Du et al., 2001) . Antisense riboprobes were made from linearized full length Danio rerio sparc cDNA (GenBank Accession number: BC071436) (primers: forward 5′TGCTTAGGCTGAAACT-CAAGATGAG3′; reverse 5′GCATCAATGGAAGACGTCCT-TAGAT3′) and the partial Danio rerio Col2a1 cDNA (GenBank Accession number U23822) (primers: forward 5′CAGAGGATT-CACTGGTCTGCAGGG3′; reverse: 5′ TCCACTCC-GAACTCCTGATCTGCTC3′). Other antisense RNA probes used in this study were sox9a and sox9b (Chiang et al., 2001) , dlx2a (Akimenko et al., 1994) , otx1 (Whitfield et al., 1996) , stm (Sollner et al., 2003 ), dlx3b (Ekker et al., 1992 , cldna (Kollmar et al., 2001) , eya1 (Hammond et al., 2003) , msxc (Ekker et al., 1992) and atp1a1a.4 (Blasiole et al., 1995) .
mRNA rescue
To generate the capped mRNA, zebrafish sparc cDNA (GenBank Accession number: BC071436) was subcloned into pCS2+ plasmids. Capped mRNA was transcribed in vitro using the SP6 Message Machine Kit (Ambion). The PCS2 + -sparc construct used in the rescue experiments includes a Kozak sequence upstream of the ATG, instead of the endogenous zebrafish sequence, resulting in five mismatches between the antisense sequences and the rescue mRNA. Thus, the capped mRNA rescue constructs were not susceptible to the MOs. Furthermore, because the sparc mRNA does not contain the intron sequences targeted by the splicing morpholino, the same sparc mRNA can be used, in combination with the translation or splice-blocking morpholinos, for the RNA rescue experiment. mRNA was injected into 1-to 2-cell stage embryos either alone or in the presence of a MO. For each rescue experiment, the amount of mRNA injected was titrated for the maximal doses that could be injected. For rescue experiments, approximately 1 nl of 0.5 mM (4 μg/μl) ATG-MO or 1 mM (8 μg/μl) E3I3-MO was injected together with 1 nl two different mRNA concentrations (325 μg/ml and 750 μg/ml) per embryo. Approximately 200 embryos were used. Around 50 embryos were co-injected with each MO (and the two different sparc RNA concentrations).
FITC-phalloidin staining
Whole-mount embryos were stained for actin with FITCphalloidin as described previously (Haddon and Lewis, 1996) , mounted in Vectashield (Vector Laboratories) and imaged with a BioRad confocal microscope.
Cartilage staining
Alcian blue was used for cartilage staining in fixed embryos as described (Kimmel et al., 1998; Miller et al., 2000) . Briefly, fixed embryos were rinsed with 100 mM Tris pH7.5/10 mM MgCl 2 and stained overnight with 0.04% alcian blue, 80% ethanol, 100 mM Tris pH7.5, 10 mM MgCl 2 . After a series of washes with 80%, 50% and 25% ethanol/Tris each for 10 min, embryos were treated with 0.5% KOH, 3% H 2 O 2 for 20 min. Stained embryos were preserved and observed in 50% glycerol, 0.1% KOH solution.
